Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Lemzoparlimab (Anti-CD47) For research use only.
Not for use in humans.

Lemzoparlimab (Anti-CD47)

Synonyms: TJ011133; TJC4

Lemzoparlimab (anti-CD47) is a human monoclonal antibody targeting the human cell surface antigen CD47 with potential phagocytosis-inducing and antineoplastic activities. MW: 145.58 KD.

Lemzoparlimab (Anti-CD47)

Purity & Quality Control

Batch: A292101 Purity: 99% Protein concentration: 10mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective CD markers Inhibitors

Biological Activity

Description Lemzoparlimab (anti-CD47) is a human monoclonal antibody targeting the human cell surface antigen CD47 with potential phagocytosis-inducing and antineoplastic activities. MW: 145.58 KD.

Product Details

CAS No. 2377483-71-9
Molecular Weight 145.58
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Lemzoparlimab (Anti-CD47) | Lemzoparlimab (Anti-CD47) supplier | purchase Lemzoparlimab (Anti-CD47) | Lemzoparlimab (Anti-CD47) cost | Lemzoparlimab (Anti-CD47) manufacturer | order Lemzoparlimab (Anti-CD47) | Lemzoparlimab (Anti-CD47) distributor